In the draft guidance, the FDA recommends that manufacturers design new X-ray imaging devices with protocols and instructions that address use on pediatric patients. It also proposes manufacturers that do not adequately demonstrate their new X-ray imaging devices are safe and effective in pediatric patients should include a label on their device that cautions against use in pediatric populations.
The FDA scheduled a workshop for July 16 to discuss the draft guidance. To view the draft guidance in full, click here.
Related Articles on Radiation Safety:
Dedicated Pediatric Imaging Department Could Reduce Radiation Dosage
BCBS Michigan’s Quality Improvement Efforts Saved $232M
CoxHealth in Missouri Settles Third of Radiation Overdose Cases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
